MDI improves patient outcomes and reduces payer costs by enabling providers to offer data-driven polypharmacy management (MTM) across all populations. The company developed an AI-based, personalized drug therapy system that records and manages essential drug information to ensure the efficacy and safety of treatments and the early detection of potential medication-related problems.
Polypharmacy management (MTM) is a proven cost and life-saving practice; however, very few patients benefit from MTM due to the current manual high-cost and inefficient process that payers only cover for the highest risk populations. MDI seeks to democratize and optimize MTM for all populations by digitizing the workflow and analyzing the underlying patient data. MDI is working with leading providers and payers in Israel and the US across different use-cases.